Telomerase activation cooperates with inactivation of p16 in early head and neck tumorigenesis

por Soria, J C, Morat, L, Commo, F, Dabit, D, Perie, S, Sabatier, L, Fouret, P
Publicado 2001

Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer

por Lecharpentier, A, Vielh, P, Perez-Moreno, P, Planchard, D, Soria, J C, Farace, F
Publicado 2011

Precision medicine in the era of multi-omics: can the data tsunami guide rational treatment decision?

por Aldea, M., Friboulet, L., Apcher, S., Jaulin, F., Mosele, F., Sourisseau, T., Soria, J.-C., Nikolaev, S., André, F.
Publicado 2023

Detection of circulating carcinoma cells by telomerase activity

por Gauthier, L R, Granotier, C, Soria, J-C, Faivre, S, Boige, V, Raymond, E, Boussin, F D
Publicado 2001

BMS-690514, a VEGFR and EGFR tyrosine kinase inhibitor, shows anti-tumoural activity on non-small-cell lung cancer xenografts and induces sequence-dependent synergistic effect with...

por Loriot, Y, Mordant, P, Dorvault, N, De la motte Rouge, T, Bourhis, J, Soria, J-C, Deutsch, E
Publicado 2010

Detection of HER-2/neu-positive circulating epithelial cells in prostate cancer patients

por Ady, N, Morat, L, Fizazi, K, Soria, J-C, Mathieu, M-C, Prapotnich, D, Sabatier, L, Chauveinc, L
Publicado 2004

Differential expression of telomerase reverse transcriptase (hTERT) in lung tumours

por Lantuejoul, S, Soria, J C, Moro-Sibilot, D, Morat, L, Veyrenc, S, Lorimier, P, Brichon, P Y, Sabatier, L, Brambilla, C, Brambilla, E
Publicado 2004

A phase I, dose-finding study of sunitinib in combination with irinotecan in patients with advanced solid tumours

por Boven, E, Massard, C, Armand, J P, Tillier, C, Hartog, V, Brega, N M, Countouriotis, A M, Ruiz-Garcia, A, Soria, J C
Publicado 2010

High level of chromosomal instability in circulating tumor cells of ROS1-rearranged non-small-cell lung cancer

por Pailler, E., Auger, N., Lindsay, C. R., Vielh, P., Islas-Morris-Hernandez, A., Borget, I., Ngo-Camus, M., Planchard, D., Soria, J.-C., Besse, B., Farace, F.
Publicado 2015

Intervention strategies for microbial therapeutics in cancer immunotherapy

por Gopalakrishnan, V., Weiner, B., Ford, C.B., Sellman, B.R., Hammond, S.A., Freeman, D.J., Dennis, P., Soria, J-C., Wortman, J.R., Henn, M.R.
Publicado 2020

ERK1/2 is activated in non-small-cell lung cancer and associated with advanced tumours

por Vicent, S, López-Picazo, J M, Toledo, G, Lozano, M D, Torre, W, Garcia-Corchón, C, Quero, C, Soria, J-C, Martín-Algarra, S, Manzano, R G, Montuenga, L M
Publicado 2004

Radiosensitization by a novel Bcl-2 and Bcl-X(L) inhibitor S44563 in small-cell lung cancer

por Loriot, Y, Mordant, P, Dugue, D, Geneste, O, Gombos, A, Opolon, P, Guegan, J, Perfettini, J-L, Pierre, A, Berthier, L K, Kroemer, G, Soria, J C, Depil, S, Deutsch, E
Publicado 2014

Safety and clinical activity of the Notch inhibitor, crenigacestat (LY3039478), in an open-label phase I trial expansion cohort of advanced or metastatic adenoid cystic carcinoma

por Even, C., Lassen, U., Merchan, J., Le Tourneau, C., Soria, J-C, Ferte, C., Ricci, F., Diener, J. T., Yuen, E., Smith, C., Oakley, G. J., Benhadji, K. A., Massard, Christophe
Publicado 2019

A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas

por Farace, F, Massard, C, Vimond, N, Drusch, F, Jacques, N, Billiot, F, Laplanche, A, Chauchereau, A, Lacroix, L, Planchard, D, Le Moulec, S, André, F, Fizazi, K, Soria, J C, Vielh, P
Publicado 2011

1688P Outcome of older cancer patients infected with COVID-19 at Gustave Roussy Cancer Center

por Hauchecorne, M., Baldini, C., Foulon, S., Bayle, A., Gachot, B., Pommeret, F., Willekens, C., Griscelli, F., Netzer, F., Balleyguier, C., Ammari, S., André, F., Scotté, F., Besse, B., Soria, J-C., Barlesi, F., Albiges, L.
Publicado 2020

Severe COVID-19 in patients with hematological cancers presenting with viremia

por Michot, J.M., Hueso, T., Ibrahimi, N., Pommeret, F., Willekens, C., Colomba, E., Francis, S., Bayle, A., Cournède, P.H., Merad, M., Foulon, S., Albiges, L., Gachot, B., Barlesi, F., Soria, J.C., Ribrag, V., Griscelli, F.
Publicado 2021

Dabrafenib plus trametinib in patients with BRAF V600E-mutant anaplastic thyroid cancer: updated analysis from the phase II ROAR basket study

por Subbiah, V., Kreitman, R. J., Wainberg, Z. A., Cho, J. Y., Schellens, J. H. M., Soria, J. C., Wen, P. Y., Zielinski, C. C., Cabanillas, M. E., Boran, A., Ilankumaran, P., Burgess, P., Romero Salas, T., Keam, B.
Publicado 2022

Prediction of early death among patients enrolled in phase I trials: development and validation of a new model based on platelet count and albumin

por Ploquin, A, Olmos, D, Lacombe, D, A'Hern, R, Duhamel, A, Twelves, C, Marsoni, S, Morales-Barrera, R, Soria, J-C, Verweij, J, Voest, E E, Schöffski, P, Schellens, J H, Kramar, A, Kristeleit, R S, Arkenau, H-T, Kaye, S B, Penel, N
Publicado 2012

1639P Impact of COVID-19 on ongoing oncological and hematological treatment strategy

por Bayle, A., Ouali, K., Colomba, E., Ibrahimi, N., Foulon, S., Gachot, B., Willekens, C., Stoclin, A., Merad, M., Griscelli, F., Sun, R., Ammari, S., Michot, J-M., André, F., Scotté, F., Besse, B., Soria, J-C., Barlesi, F., Albiges, L., Pommeret, F.
Publicado 2021

1617P Sustained cancer clinical trial activity during the COVID-19 pandemic

por Bayle, A., Baldini, C., Romano, P. Martin, Michot, J-M., Champiat, S., Bahleda, R., Gazzah, A., Marabelle, A., Verlingue, L., Geraud, A., Morel, D., Michiels, S., Ribrag, V., Hollebecque, A., Albiges, L., Besse, B., Soria, J-C., Massard, C., Barlesi, F., Postel-Vinay, S.
Publicado 2021